PEA15

UniProt ID: A0A9L0RWM8
Organism: Equus caballus
Review Status: IN PROGRESS
๐Ÿ“ Provide Detailed Feedback

Gene Description

PEA15 is a death-effector-domain regulatory protein that binds ERK kinases and controls their activity and intracellular distribution. It also modulates death-receptor signaling through FADD/caspase-8 interactions. Mammalian PEA15 regulates glucose uptake through effects on glucose-transporter trafficking rather than acting as a membrane transporter. The selected horse protein contains the complete conserved human PEA15 sequence with an additional N-terminal extension.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000165 MAPK cascade
IEA
GO_REF:0000002
ACCEPT
Summary: PEA15 directly modulates ERK MAP kinase signaling.
Reason: The ERK2โ€“PEA15 structures and biochemical experiments establish direct binding and altered kinase conformation/activity. Participation in the MAPK cascade is a supported regulatory role; PEA15 need not itself be a kinase.
Supporting Evidence:
PMID:23575685
occupying two key docking sites of ERK2
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Cytoplasmic/cytosolic localization is consistent with PEA15 signaling regulation.
Reason: PEA15 binds cytoplasmic ERK and regulates its distribution; the soluble death-effector-domain architecture and curated localization support this compartment. The selected horse sequence retains the entire human core, but its extra N-terminal segment is not assumed to be functionally neutral.
Supporting Evidence:
file:human/PEA15/PEA15-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
GO:0042981 regulation of apoptotic process
IEA
GO_REF:0000002
ACCEPT
Summary: PEA15 regulates apoptotic signaling through death-effector-domain interactions.
Reason: Human-cell overexpression and co-precipitation experiments demonstrate inhibition of Fas/TNFR1-dependent caspase-8 activation involving FADD. This supports apoptotic regulation; the conserved horse core supports transfer of the mechanism.
Supporting Evidence:
PMID:10442631
Thus, PED/PEA-15 is an endogenous protein inhibiting FAS and TNFR1-mediated apoptosis.
GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
IEA
GO_REF:0000117
ACCEPT
Summary: PEA15 can inhibit death-receptor-mediated extrinsic apoptosis.
Reason: The human primary experiment shows protection from FasL and TNFalpha effects and impaired FADDโ€“caspase-8 association. This is the specific pathway represented by the annotation. The horse protein preserves the human death-effector-domain sequence, although the effect of its N-terminal extension has not been measured.
Supporting Evidence:
PMID:10442631
Thus, PED/PEA-15 is an endogenous protein inhibiting FAS and TNFR1-mediated apoptosis.

Core Functions

Direct binding and conformational regulation of ERK kinase activity and distribution.

Directly Involved In:
Cellular Locations:
Supporting Evidence:

References

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

External Prediction Reviews

These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.

ProtNLM2 External predictions

View prediction review YAML ยท PEA15-protnlm-predictions-review.yaml ยท Review status: COMPLETE

PEA15 has experimentally supported regulatory effects on glucose-transporter trafficking. Whether the exact carbohydrate-transport process annotation is justified for the selected horse protein remains uncertain.

Source documents: genes/HORSE/PEA15/PEA15-bioinformatics/RESULTS.md ยท genes/human/PEA15/PEA15-uniprot.txt ยท publications/PMID_9670003.md

Review score: 2 = concordant with evidence; 1 = uncertain; 0 = discordant with evidence. This is an assessment score, not a model probability.

GO:0008643 carbohydrate transport GO_BP
UNC โ€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 ยท Version: UniProt API snapshot 2026-09-08
Review rationale: Human PEA15 changes GLUT1/GLUT4 surface recruitment and insulin-stimulated glucose transport, so this prediction must not be rejected merely because PEA15 lacks a transporter fold. The selected horse protein retains the complete human core at 100% identity with a 46-residue N-terminal extension. However, the inspected experimental evidence supports regulation of transport, whereas GO:0008643 denotes directed carbohydrate movement; regulation is not automatically the same biological-process assertion. The exact horse process has no target GOA overlap and neither direct horse transport evidence nor a demonstrated mechanistic participation beyond regulation is available. The prediction remains uncertain rather than being classified as a nonparalog error.
Supporting Evidence:
  • PMID:9670003: "Transfection of PED/PEA-15 in differentiating L6 skeletal muscle cells increases the content of Glut1 transporters on the plasma membrane and inhibits insulin-stimulated glucose transport and cell-surface recruitment of Glut4"
  • file:HORSE/PEA15/PEA15-bioinformatics/RESULTS.md: "Global alignment of cached UniProt sequences gives **130/130 identical paired residues (100.0%)**."

๐Ÿ“š Additional Documentation

Notes

(PEA15-notes.md)

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

Bioinformatics Results

(RESULTS.md)

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

๐Ÿ“„ View Raw YAML

Loading supporting contentโ€ฆ

Download this section (compressed HTML)